Pin it
November 21, 2014 | Last Updated 12:40 AM
Loading
Image Loading

Subscribe to newsletters

 
 
MOBILE RSS twitter facebook
Africa & World
Apr 29 2012 7:14AM
 
US approves antibiotic to treat, prevent plague
Johnson & Johnson building in Madrid, Spain. Getty images
print
divider
mail
divider
Bookmarkl and ShareShare
divider
share
 
Rate This Story close
|

U.S. regulators have approved use of a powerful Johnson & Johnson antibiotic to treat plague, an extremely rare, sometimes-deadly bacterial infection.

The Food and Drug Administration also approved Levaquin, known generically as levofloxacin, to reduce the risk of people getting plague after exposure to the bacteria that cause it. Called Yersinia pestis, the bacteria are considered a potential bioterrorism agent.

Plague mainly occurs in animals. People can get it from bites from infected fleas or contact with infected animals or humans. About 1,000 to 2,000 human cases occur worldwide each year.

The FDA approved Levaquin for plague after tests on African green monkeys infected with the bacteria in a lab found 94 percent of the monkeys given Levaquin survived.

Sapa

|
print
divider
mail
divider
Bookmarkl and ShareShare
divider
share
 
 
Comment Now
 
 
Close

Name:*   

Email:*   

Comment: *


 
Close Name:

Email:  

Subject:

Description:
               

 
 
http://www.dmma.co.za/ sudoku